AbCellera Biologics Inc. Common Shares (ABCL) 1WNASDAQ:ABCL
On the weekly timeframe, a strong long setup is forming, marking the end of a multi-year downtrend and the formation of a solid base for medium-term growth. The key technical argument is the classic mirror level in the 5.32–5.80 range, which previously held back buyers for a long time and is now successfully being tested from above as a new support zone.
The bullish case is strengthened by price holding above all key moving averages, which are now turning upward, forming an additional protective shield for the uptrend. A clean impulsive breakout from the global descending trendline has been confirmed, so the current consolidation represents a healthy technical retest of the broken structure.
Position building is relevant within the current buy zone, where the appearance of long lower wicks on weekly candles clearly confirms that large players are defending this range. The main medium-term profit target is located at strong historical resistance around 14.97 dollars, which, given current entry levels, offers an excellent risk-to-reward ratio.
This analysis is for informational purposes only and does not constitute individual investment advice. Proper risk management is required. 
Long
TSLA H1 MAP: 8.2/10 Wall at 415 vs Strong 389 Support▪️ TSLA H1 SNAPSHOT — EXECUTIVE SUMMARY
▪️ TSLA is currently trading near 394.79, hovering just above a strong support shelf after being rejected from the heavy supply cluster overhead. Market structure is consolidating, with price boxed between a well-defended floor below and a stack of stiff resistance above.
▪️ Primary outlook is neutral-to-cautious — the reaction at 389 is the key tell. While that shelf holds, buyers can attempt another push into resistance; losing it flips momentum lower toward the deeper demand zone.
▪️ Key resistance zone: 415, where sellers have defended 41 times — the strongest ceiling on the chart — and are expected to lean hard on first test. Above that sits a dense band at 426, 436, then 444.
▪️ Major defense line: 389 — a strong level at 24 retests. Holding here keeps the range intact; a decisive break below opens the door for a corrective slide.
▪️ Primary downside targets: 366, then 354.40, where liquidity and demand are stacked.
▪️ Major liquidity magnet below: 366–354 — this zone could trigger a strong bounce or reversal once tested.
▪️ Bullish scenario: If buyers hold 389 and reclaim 415, the path opens toward 426, with 436 as the extended upside objective.
▪️ KEY LEVELS
RESISTANCEs
▪️ 444.00 — ★ 5.6 Weak · 46 retests
▪️ 436.00 — ★★★ 7.8 Strong · 21 retests
▪️ 426.00 — ★ 4.7 Weak · 50 retests
▪️ 415.00 — ★★★★ 8.2 Very Strong · 41 retests
▪️ Current Price: 394.79
SUPPORTs
▪️ 389.00 — ★★★ 7.7 Strong · 24 retests
▪️ 366.00 — ★★★ 7.3 Strong · 14 retests
▪️ 354.40 — ★ 4.6 Weak · 19 retests
ProjectSyndicate Levels Desk — Overview of key S/R zones for TSLA, NVDA, NQ, ES, GC & JPN225 traders every week. Subscribe to stay up to date with the latest levels. 
Long
Long
NVDA Pinned Between 200 and 212 - 218 or 184 up next?▪️ NVDA H1 SNAPSHOT — EXECUTIVE SUMMARY
▪️ NVDA is currently trading near 203.54, holding just above a strong support shelf after failing to reclaim overhead supply. Market structure is consolidating, with price pinned between a well-defended floor below and moderate resistance above.
▪️ Primary outlook is neutral-to-constructive — the reaction at 200.00 is the key tell. While that shelf holds, buyers can attempt another push higher; losing it exposes the deeper demand stack below.
▪️ Key resistance zone: 212.00, where sellers have defended 18 times and are expected to lean again on first test. Above that sits 218.00 as the extended ceiling.
▪️ Major support / defense line: 200.00 — a strong level at 22 retests. Holding here keeps the bullish attempt alive; a decisive break below opens the door for a corrective slide.
▪️ Primary downside targets: 190.50, then 184.50, where liquidity and demand are stacked.
▪️ Major liquidity magnet below: 184.50–178.70 — this zone could trigger a strong bounce or reversal once tested.
▪️ Bullish scenario: If buyers reclaim and hold above 212.00, the path opens toward 218.00 as the primary upside objective.
▪️ KEY LEVELS
RESISTANCEs
▪️ 218.00 — ★ 4.5 Weak · 9 retests
▪️ 212.00 — ★★ 6.4 Moderate · 18 retests
▪️ Current Price: 203.54
SUPPORTs
▪️ 200.00 — ★★★ 7.3 Strong · 22 retests
▪️ 190.50 — ★★★ 7.7 Strong · 32 retests
▪️ 184.50 — ★ 4.6 Weak · 46 retests
▪️ 178.70 — ★ 4.5 Weak · 48 retests
ProjectSyndicate Levels Desk — Overview of key S/R zones for NVDA, NQ, ES, GC & JPN225 traders every week. Subscribe to stay up to date with the latest levels. 
Long
Oracle Plunges to 52-Week Low Amid Broad Sell-Off!Oracle Corporation has experienced a brutal and unrelenting sell-off over the past four weeks, with its stock price eroding by approximately 28% to settle at a daunting 52-week nadir near the $132 mark. This precipitous decline represents one of the most severe drawdowns for the legacy tech giant in recent memory, as the market continues to punish the stock amidst a confluence of internal financial anxieties and shifting sector-wide investment preferences. The magnitude of this drop has not only erased substantial shareholder wealth but has also placed Oracle firmly in the spotlight as a bellwether for the growing bifurcation within the broader artificial intelligence and cloud computing landscape.
The bearish sentiment currently gripping Oracle is fueled by several critical and interrelated headwinds that have rattled even the most steadfast institutional investors. Foremost among these are mounting anxieties regarding extreme customer concentration, which leaves the company's recurring revenue streams dangerously vulnerable to churn, pricing renegotiations, or sudden budget cuts from its largest enterprise clients. Should any of these major accounts scale back their commitments, Oracle's top-line growth could face immediate and substantial headwinds. Additionally, analysts have flagged significant projected free cash flow deficits, raising serious eyebrows about the sustainability of Oracle's aggressive and capital-intensive infrastructure build-out, which is necessary to compete in the generative AI arms race but comes at a staggering near-term cost. Compounding these financial strains is the looming threat of equity dilution, as the firm may be compelled to issue additional shares to finance its expansive data center upgrades and acquisition strategies, thereby eroding existing shareholder value and applying further downward pressure on earnings per share.
Interestingly, the market reaction to Oracle's cloudy outlook and subsequent downgrade has created a stark dichotomy within the broader AI-cloud ecosystem, effectively splitting the sector into two distinct narratives. On one hand, asset-light software names, exemplified by high-growth enterprises like Cloudflare and Snowflake, have managed to capture upward momentum and relative strength. Investors appear to be gravitating toward their scalable, high-margin, subscription-based business models, which require far less physical infrastructure investment to generate growth. Conversely, capital-expenditure-heavy enterprises—burdened by the substantial hardware, real estate, and data center costs required to deploy next-generation AI capabilities—have continued to languish in the wake of Oracle's struggles. This divergence underscores a market that is increasingly penalizing companies with hefty balance-sheet commitments while rewarding those with leaner, more agile operational structures.
Despite this grim near-term price action and the litany of operational risks on the horizon, the overarching sentiment among the sell-side analyst community remains remarkably resilient, constructive, and decidedly bullish. The consensus view continues to project a robust recovery trajectory for Oracle, anchored by a median price target that hovers impressively near $251.85. This optimistic long-term outlook is overwhelmingly supported by the current ratings distribution, which boasts an astonishing 37 buy recommendations standing in stark contrast to a mere solitary sell rating. This glaring disparity suggests that institutional analysts are intentionally looking past the current turbulence, choosing instead to bet on Oracle's fundamental positioning within the enterprise software market, its evolving cloud strategy, and the eventual monetization of its AI investments—provided the company can successfully navigate its current risk profile and restore investor confidence.
From a pure technical analysis perspective, traders and chartists are now closely monitoring key downside support levels to gauge potential stabilization points and possible entry opportunities. The primary psychological and technical floor rests at the $120 level, which historically has acted as a significant demand zone. Should selling pressure persist and breach that threshold, subsequent safety nets are identified at $100 and finally $80, representing deeper retracement levels that would signal severe capitulation. On the upside, a near-to-medium term recovery target has been outlined at $180.00, representing a significant percentage rebound from current depths and a critical resistance level that bulls must conquer to reverse the prevailing downtrend. Ultimately, while the data warrants a cautious stance given the identified operational and financial risks, the glaring chasm between Oracle's current distressed valuation and the lofty consensus analyst forecasts underscores a high-stakes battleground for bulls betting on a dramatic reversal versus bears anticipating further erosion in the months ahead. 
Long
Long 
ONDS Stock Plunges to Seven-Month Low Amid Dilution Fears!Ondas Holdings has found itself entrenched in a prolonged and punishing slump, extending its losing streak to six consecutive weeks as the autonomous systems developer's share price cascaded to a seven-month nadir of $7.26 per share. This relentless downward trajectory, which has shaved considerable value off the company's market capitalization, arrives at a peculiar inflection point: while the stock chart paints a grim picture of sustained selling pressure, a closer examination of the underlying business reveals a flurry of strategic activity, transformative acquisitions, and burgeoning defense contracts that have convinced a vocal segment of retail investors to view this trough as a potential springboard rather than a sinking ship.
Market Pressures and Dilution Concerns Fuel the Selloff
The primary drivers behind this protracted slide appear to be rooted more in capital-market mechanics than in any fundamental deterioration of Ondas' operational performance. The sell-off intensified after the company executed several aggressive acquisition moves, which, while strategically sound in expanding its technological capabilities, necessitated a significant expansion of its outstanding share base. To finance its rapid growth ambitions, Ondas increased its authorized share count, triggering widespread investor trepidation over potential dilution. This concern over equity overhang has weighed heavily on sentiment, as existing shareholders brace for the possibility that future issuances could erode per-share earnings and dilute their current stakes. Consequently, even as the company posts encouraging operational milestones, the specter of supply-side pressure has overwhelmed bullish narratives, driving the stock to levels not witnessed since the closing months of 2025.
Transformative Acquisition Reshapes Ondas' Defense Footprint and Financial Trajectory
In a strategic masterstroke aimed at vaulting Ondas into the upper echelons of the defense-tech arena, the company recently finalized its monumental $875.8 million acquisition of DZYNE Technologies. This deal, which represents one of the most significant consolidations in the counter-drone and autonomous aerospace sector, brings under Ondas' umbrella a well-established defense enterprise specializing in long-endurance autonomous aircraft and advanced counter-unmanned aerial systems (counter-UAS). Structurally, the transaction was financed through a balanced mix of $200 million in cash and $675 million in equity, reflecting a blend of financial prudence and strategic leveraging of Ondas' stock currency. Critically, DZYNE arrives with a distinct competitive advantage that distinguishes it from many early-stage drone startups: the business boasts existing operational infrastructure, mature customer relationships, and, perhaps most importantly, positive EBITDA. This profitability profile stands in stark contrast to the cash-burning norms of the industry, providing Ondas with an immediate lift in financial health and operational credibility.
Elevated Revenue Guidance Signals a New Era of Growth
Buoyed by the integration of DZYNE's robust revenue streams and its expansive contract pipeline, Ondas has responded with a significantly upgraded financial outlook. Management has now raised its 2026 revenue expectations to a minimum of $525 million, representing a substantial 34% increase over the company's previous internal projections. This upward revision not only underscores the accretive nature of the acquisition but also signals a powerful acceleration in Ondas' top-line growth trajectory, positioning the combined entity as a formidable player capable of capturing a larger share of the rapidly expanding defense and security markets.
High-Profile Contracts and Strategic Alliances Bolster Long-Term Prospects
Beyond the acquisition-driven momentum, Ondas' wholly owned Sentrycs subsidiary is actively carving out a prominent niche in the global counter-drone landscape. The division recently secured pivotal contracts to provide comprehensive airspace protection and threat-detection capabilities during the highly anticipated 2026 FIFA World Cup, a marquee event that will thrust Sentrycs' technology onto an international stage, demonstrating its efficacy in securing large-scale public venues against emerging drone-based threats. Furthermore, Ondas has forged a strategic collaboration with defense prime contractor Lockheed Martin (LMT) to integrate Sentrycs' proprietary counter-drone technology into a broader, next-generation defense platform designed to detect, track, and neutralize hostile unmanned aircraft. This partnership not only validates the technical sophistication of Ondas' offerings but also opens the door to substantial future procurement opportunities across military and governmental channels.
Retail Sentiment Turns Bullish Amid the Volatility
Against this complex backdrop of short-term stock erosion and long-term transformational growth, retail traders congregating on the Stocktwits platform have largely shrugged off the prevailing market pessimism. Many vocal members of this community have branded the seven-month low as a "rare opportunity" to accumulate shares at what they perceive to be a deeply discounted valuation relative to the company's intrinsic potential. For these investors, the current sell-off represents a classic overreaction to transient dilution anxieties, obscuring the formidable value inherent in Ondas' expanding defense portfolio, its rising revenue guidance, and its strategic positioning at the forefront of the autonomous security revolution. Whether this contrarian bet pays off remains to be seen, but the fervent conviction among retail holders underscores a compelling narrative of high-risk, high-reward speculation at the intersection of defense technology and next-generation aviation.
Long
RCLBullish Analysis: Royal Caribbean Group (NYSE: RCL)
Royal Caribbean remains one of the strongest companies in the global travel and leisure sector. Despite macroeconomic concerns, the company continues to outperform peers thanks to exceptional demand, premium pricing, and industry-leading execution.
Why I'm Bullish
1. Record Booking Demand
Booking volumes remain at historically high levels.
Many 2026 sailings were booked well in advance at record prices.
Management has stated that demand recovered quickly even after temporary geopolitical disruptions.
2. Premium Pricing Power
Unlike many travel companies that compete on discounts, Royal Caribbean continues raising prices while maintaining strong occupancy.
This shows:
Strong brand loyalty
High consumer willingness to spend on experiences
Pricing power that supports expanding margins
3. Industry-Leading Fleet
Royal Caribbean's newest ships (Icon Class, Star of the Seas, Legend of the Seas) generate significantly higher onboard spending than older vessels.
New ships offer:
Higher ticket prices
Better fuel efficiency
More onboard revenue
Greater operating margins
This creates a long-term competitive advantage.
4. Strong Financial Momentum
Recent results showed:
Double-digit revenue growth
Earnings beating expectations
Management maintaining confidence in long-term growth despite higher fuel costs.
Continued shareholder returns through dividends and share repurchases.
5. Cruise Industry Tailwinds
Consumers continue prioritizing experiences over goods.
Key trends include:
Millennials becoming a larger share of cruise passengers
Growth in multigenerational family travel
Cruise vacations remaining attractive relative to land-based alternatives.
6. Growth Pipeline
Royal Caribbean continues expanding through:
New Icon-class ships
Exclusive beach clubs and private destinations
Expanded loyalty ecosystem
Additional ship orders extending growth into future years.
Risks
The bullish thesis isn't without risks:
Rising fuel prices can pressure margins.
Economic slowdowns may reduce discretionary travel spending.
Geopolitical events can temporarily affect itineraries and bookings.
The company still carries meaningful debt from the pandemic era, although leverage has been improving.
Investment Thesis
Royal Caribbean has evolved from a post-pandemic recovery story into a high-quality growth company. Strong demand, premium pricing, expanding onboard revenue, and continuous fleet innovation position it well for continued earnings growth. Analysts have also highlighted Royal Caribbean as one of the strongest operators in the cruise industry, expecting continued earnings expansion over the next several years.
Bullish Rating: 8.8/10
Long-term outlook: Bullish
Investment horizon: 12–36 months
The combination of resilient consumer demand, industry-leading execution, and a robust pipeline of new ships makes Royal Caribbean one of the more compelling growth opportunities in the travel sector. 
Long
CRDO: Multi-TF Bearish Divergence Signals a Major CorrectionCRDO has hit the target shared previously (see attached post).
Now it appears to be entering a significant corrective phase after an extended bullish run.
The stock has developed bearish divergence on both the Daily and Weekly timeframes, indicating that bullish momentum has been fading despite price making new highs. It recently reached the upper boundary of a rising wedge near 308, where sellers stepped in aggressively.
Adding to the bearish case, price formed an Evening Star reversal pattern, followed by a gap-down session that confirmed the shift in momentum. The subsequent breakdown below the wedge occurred on nearly four times the average daily trading volume, suggesting strong institutional selling rather than routine profit-taking.
In the short term, CRDO could attempt a throwback to retest the breakdown area around 260. However, unless that level is reclaimed decisively, the path of least resistance remains to the downside.
Key support levels to watch are:
199 – First major support
149 – Secondary support
86–90 – Long-term measured target based on the wedge breakdown
Bearish thesis invalidation: A strong daily close above 310 would invalidate the current bearish setup and shift the outlook back in favor of the bulls.
While short-term bounces are always possible, the combination of multi-timeframe bearish divergence, a completed rising wedge breakdown, heavy distribution volume, and a confirmed reversal candlestick pattern suggests that the correction may have only just begun. 
Short
Long
Short 
Long
Short
Long
Long
Long
Short
AAPL | The Trap - Why Apple’s AI Halo Is Fading | SHORTIf you think the $4.37 trillion "iStock" is invincible, you might want to check the expiration date on this rally.
While everyone is busy hyperventilating over "Apple Intelligence," Siri upgrades, and WWDC software reveals, the chart is quietly downgrading its future. Here’s why we’re looking at a potential 65% liquidation event at the Apple Store.
1. The Bearish Divergence (The Momentum Whisperer)
Price is making "Higher Highs" up near $315 that look great on a billboard, but the RSI (sitting uncomfortably in the 70s) and MACD are making "Lower Highs" on the longer timeframes. This isn't just a hiccup; it’s a massive Bearish Divergence. The stock is climbing the mountain, but it's running completely out of oxygen. When the momentum gives out, gravity takes over—and it’s a devastatingly long way down to the next structural "Anchor Point."
2. The Wyckoff Distribution: The "Smart Money" Exit
We are tracing a textbook Wyckoff Distribution right now. We’ve seen the Buying Climax fueled by the new $100 billion share buyback announcement, the Automatic Reaction, and now we’re floating in that dangerous "Upthrust" zone. The smart money has already packed their bags and locked in profits from the early 2026 run; they’re currently busy handing the bags over to retail traders who think Apple cautiously sitting out the AI spending arms race is just a "genius, cost-saving dip."
3. Price Action & Volume (The Hollow Climb)
Take a look at the volume during this push toward all-time highs—it’s declining while the price edges higher. That’s a "hollow" move. In technical terms: there’s no conviction behind this rally. We’re staring at a massive liquidity void below. The 200-day moving average sits around $260, but once that floor snaps, the trap door opens. There is absolutely no structural support until we hit the multi-year consolidation zones, pointing toward a brutal 65% retracement down to the $110–$120 level.
4. The Denial Phase: "It’s Different This Time"
We are currently entering the Denial Phase of the market cycle. You'll hear it in the comments: "Apple Intelligence will trigger an iPhone supercycle," "China tariff risks are overblown," or "Services revenue just hit $31 billion—they're unstoppable!" This psychological buffer is the only thing keeping AAPL's premium 36x P/E multiple afloat. But remember: the bigger the denial, the harder the eventual capitulation when the "longs" finally realize the hardware replacement cycle is permanently broken and the V-shaped recovery isn't coming.
5. Short Interest: The Fuel for the Fall
While people don't usually "squeeze" a $4 trillion behemoth, the remarkably low short interest actually works against Apple here. There are practically no shorts left to "cover" and provide a parachute during a flash crash. When the geopolitical fears return or earnings stumble, it’s a one-way street with no forced buyers in sight. When the panic starts, the race to the exits will turn a standard correction into a historic haircut. 
Short
Long 
BioNTech (BNTX) LONG — 4H ALMA Setup (WR 80%)█ SETUP
NASDAQ:BNTX · 4H · long only.
(Context: BioNTech — mRNA platform; oncology pivot post-COVID; Pfizer Comirnaty partner.)
ALMA Averaging Strategy: ALMA 3 / σ2, SD band 2, min diff 6/1, 25% per bar, up to 4 adds, hard stop −10% from average entry.
Strategy Tester (BNTX 4H):
Win rate 80% · profit factor 2.3 · max drawdown 17%
Avg winning trade +10.6% · avg losing trade −8.8%
Typical hold ~18×4H bars on winners — biotech mean-reversion sleeve on the US cash grid
█ WHY NOW
Monday US cash open — fresh 4H ALMA long on 13 Jul 13:30 UTC ~ $91.42 .
First lot on the template at the VWAP support cluster (~$91.02–91.36) after a July grind in the low-$90s — bar-close on the 4H sleeve, not an oncology-headline or patent-win chase.
Hard stop zone −10% from fill ~ $82.28 . Exits follow Pine ALMA flip + min diff or the hard stop.
═
█ MACRO
Sector: BNTX = mRNA / immuno-oncology pivot — COVID revenue fade, pipeline catalysts (pumitamig, BNT324 prostate ADC Phase 3), ~€16.8B cash (Q1).
Tape (Jun–13 Jul): Mixed window — UPC patent win vs Promosome (02–08 Jul, Comirnaty cleared in Europe) and Lancet mRNA efficacy meta-analysis vs German manufacturing divestiture talks (~1,860 jobs, Handelsblatt/Reuters 03 Jul). $1B ADS buyback active (~$99M repurchased mid-June, avg ~$88.6). Morgan Stanley Buy maintained, PT $126→$119 (08 Jul); Morningstar 2-star «overvalued» after ~+11% over 30 days on one tape slice. Next: Q2 earnings ~04 Aug 2026 ; H2 oncology readouts on the calendar.
Execution is 4H ALMA at ~$91.42 in the support band — not a post-rally chase into MS’s trimmed PT zone (~$115–119).
█ OUTLOOK
Positive factors
- 80% WR · PF 2.3 · avg win +10.6% vs avg loss −8.8% on 109×4H trades — workable skew for a volatile biotech name
- Fresh 4H entry inside the 24h publish window — first lot at US cash, not a scale-in add
- ALMA — execution TF aligned: 4H LONG · L:1 vs avg L:3.8 — template direction matches the bar
- VWAP — support at fill: active support ~$91.02 / ~$91.36 · chart touch Support — entry sits on the lower VWAP band, not mid-range
- SMC — demand at fill: 4H bull FVG raid ~$91.42 (10 Jul) · 1D bull FVG enter ~$91.49 + OB enter normal bull — same-session demand tags
- EMA — below-session stretch (fuel): 1H Cur S:14 vs Avg S:4.2 · +0.8% dev — entry ladder stretched below on the faster TF
- Macro tailwinds in-window: UPC win + buyback execution vs restructuring noise — mixed tape suits a mean-reversion sleeve, not a breakout call
Negative factors
- ALMA — slow-TF headwind: 1D SHORT · S:5 vs avg S:4.2 · OVERHEAT-S — daily band still short-biased; adds risky if price extends without reset
- EMA — bear stack: 4H / 1D / 3D / 1W all Below — no full MTF reclaim; 4H only S:3 (+0.6% dev), not a deep crash discount
- VWAP — overhead: resistance ~$94.45 / ~$94.17 (Jul) — first mean-reversion ceiling a few percent above fill
- Restructuring headline risk: German site sales, job cuts, JPT Peptide exit — gap risk on US opens
- Analyst caution: MS PT cut · Morningstar overvalued — sentiment not uniformly bullish despite patent win
- Earnings ~04 Aug — binary biotech window ahead; 4H sleeve can whipsaw into the print
- Single first lot — no averaged discount yet if the bar extends lower before adds qualify
- Promosome may appeal UPC ruling — residual legal overhang
Takeaway: the 80% 4H template, VWAP support cluster, bull FVG/OB tags at ~$91, and 1H below-EMA stretch support a disciplined mean-reversion long at the cash open — but 1D ALMA OVERHEAT-SHORT and the full EMA bear stack cap conviction; macro is patent/buyback positive vs restructuring/analyst downgrade negative — biotech grind in the low-$90s, not a clean oncology breakout; nominal risk stays on −10% / Pine exit.
Base case: 4H ALMA holds ~$89–94 · VWAP support absorbs dips · slow work toward ~$94–95 resistance if bull FVG shelf holds.
Bear case: lose 4H ALMA · restructuring headline accelerates · pre-earnings de-risking · flush toward hard stop ~$82.28 from ~$91.42 entry.
Chart: BATS:BNTX 4H — ALMA Averaging Strategy.
Educational idea. Live position — past backtest ≠ future results. NFA. 
Long
NVDA – AI Momentum Leader In Expansion Mode | CSE Capital OptionNVIDIA remains one of the most important momentum and AI-leadership cases inside my CSE Capital — Option Decision OS, also known as the Continuation Swing Engine.
NVDA is not a normal stock in my model. It represents a very specific category: high-quality, high-momentum, high-attention and high-option-risk. That combination can create exceptional opportunities, but it can also create emotional decision-making if there is no system behind the trade. This is exactly why I analyse NVDA through the CSE framework instead of treating it as a simple “AI stock to buy.”
In earlier models, the main focus was patience and structure. NVIDIA has already shown several powerful continuation phases, but the strongest stocks can also become the most dangerous when traders start chasing every breakout without checking risk. My view is that NVDA should be respected as a market leader, but never traded without a clear technical and options-based decision process.
Inside the CSE Capital Option Decision OS, I look at NVDA through multiple layers: Fibonacci structure, trend continuation, momentum quality, reclaim zones, breakout behaviour and option feasibility. The question is not only whether NVIDIA is strong. The real question is whether the stock is offering a clean enough continuation setup and whether the option contract is still realistic from a portfolio-risk perspective.
From a technical perspective, NVDA remains a classic expansion candidate when it holds important support zones and continues to push through higher resistance areas. When a stock like this starts moving into new high territory, overhead resistance becomes less relevant and momentum can attract even more trend-following capital. But that also means discipline becomes more important, not less.
This is where the CSE model adds value. The system helps separate a strong underlying trend from an actionable option trade. A chart can look excellent while the option contract is still too expensive, too wide, too short-dated or too concentrated relative to the portfolio. Especially with a stock like NVDA, the High-Priced US Option Regime must always be respected.
For an options strategy, I do not want to chase NVIDIA simply because it is moving higher. I want structure first: support, reclaim, trend quality and continuation. Then I want confirmation: momentum, volume behaviour and the ability to hold above key levels. Only after that does the option feasibility layer become relevant.
That means checking premium size, bid/ask spread, liquidity, delta, expiry, time value, implied volatility, portfolio exposure and risk/reward before any position can become actionable. If the option is too expensive relative to the account, the correct decision can still be to wait, reduce exposure, use a spread structure or skip the trade completely.
The current NVDA case is therefore not about hype. It is about respecting one of the strongest AI momentum leaders in the market while staying disciplined enough not to confuse a strong stock with an automatic option entry.
My view: NVDA remains a core momentum leader inside the CSE Capital Option Decision OS. The bullish continuation structure stays interesting as long as the stock holds key technical zones and momentum remains constructive. But every potential option trade must still pass the full CSE feasibility and risk process.
Structure first.
Confirmation second.
Option feasibility third.
No chase, no emotion, only process.
Long 
AMZN – Silver Zone Reclaim Into Continuation Setup | CSE CapitalAmazon is currently one of the most important focus cases inside my CSE Capital — Option Decision OS, also known as the Continuation Swing Engine.
In earlier AMZN models, I treated the stock as a high-quality continuation candidate, but not as a random buy. The key idea was to wait for the right technical location: a reclaim, a support hold, or a controlled entry zone where the risk/reward for an option strategy would become more attractive. Within my model, the Silver entry zone became the most important area to monitor.
That Silver zone is now the focus.
For me, this changes the decision structure. Amazon is no longer just a broad watchlist name. It is now a daily focus case because the stock is moving around a predefined CSE entry region where continuation can develop if buyers remain in control. The setup is especially relevant because I already have exposure through the AMZN Jun 2027 235 Call, which means the goal is not to chase or randomly add risk, but to evaluate whether the original thesis is still strengthening.
This is exactly why I built the CSE Capital Option Decision OS. The software is not designed to create blind buy signals. It is designed to bring structure into the full decision process: where is the stock relative to its Fibonacci zones, where is the trend improving, where has price reclaimed an important area, and whether the option contract itself is actually feasible.
Amazon is interesting because it sits in a very important category inside my option universe. It has the quality, scale and growth profile of a major US technology leader, but the option structure can sometimes be more workable than some of the extremely high-priced megacap names. That makes AMZN a potential portfolio growth engine when the technical structure and option feasibility align.
From a technical perspective, the current focus is the Silver zone. If AMZN continues to hold this region, rebuilds momentum and starts moving toward the next higher resistance or expansion area, the bullish continuation scenario improves. The reclaim or support hold around this zone becomes a reference point for the thesis. If price fails the zone, the model prevents me from forcing a trade just because the company is strong.
For an options strategy, this remains very important: an entry zone is not a buy signal. A Silver zone, a reclaim or a strong-looking chart only tells me that the stock deserves focus. Every option idea still needs to pass the Option Feasibility + Risk Gate inside the CSE model.
That means checking premium size, bid/ask spread, liquidity, delta, expiry, time value, portfolio exposure and risk/reward before taking any action. With AMZN, this is especially important because I already have a long-dated position. The question is not only whether the chart looks attractive, but whether additional exposure would improve the portfolio or simply increase concentration risk.
The current AMZN case is therefore about process, not hype. First the model identified Amazon as a high-quality continuation candidate. Then it marked the relevant Silver entry region. Now the stock is being monitored as a daily focus case because the technical location is becoming important again.
My view: AMZN remains one of the cleaner large-cap continuation candidates inside the CSE Capital Option Decision OS. The bullish structure improves as long as the Silver zone holds and momentum continues to build. If the stock confirms strength from this area, the existing Jun 2027 235C thesis remains supported.
Structure first.
Confirmation second.
Option feasibility third.
No chase, no emotion, only process.
Long
AAPL – 291 Reclaim Into All-Time-High Breakout | CSE Capital Apple is now becoming one of the most important focus cases inside my CSE Capital — Option Decision OS, also known as the Continuation Swing Engine.
In earlier Apple models, I did not want to chase the stock directly under resistance. The key idea was to wait for a cleaner technical location: a retracement, a reclaim, or a confirmed support zone where the risk/reward for an option strategy would become more attractive. One of the most important levels in that process was the 291 area.
That level has now been reclaimed.
For me, that changes the structure. Apple is no longer just a quality stock on the watchlist. It is now moving from a “wait for retracement / wait for confirmation” case into a continuation swing case. The reclaim of 291 shows that buyers have stepped back in at an important technical zone, and the move toward / through the all-time-high area confirms that the market is again willing to price Apple higher.
This is exactly the type of situation my CSE Capital Option Decision OS was built to analyse. The software is not designed to create random buy signals. It is designed to bring structure into the decision process: where is the stock relative to its Fibonacci zones, where is the trend improving, where is the reclaim confirmed, and whether the option strategy is actually feasible from a risk perspective.
In the earlier Apple case, the system treated the stock with patience. The thesis was clear: Apple remained a high-quality name, but a strong company is not automatically a good option entry. The model preferred to wait for the right zone instead of chasing price under resistance. Now that 291 has been reclaimed and Apple is breaking into all-time-high territory, the setup becomes much more interesting.
From a technical perspective, this is a transition from recovery into expansion. A reclaim of 291 can now act as an important reference level. If Apple continues to hold above this area, the structure supports a bullish continuation scenario. The all-time-high breakout is important because it removes overhead resistance and can attract new momentum, trend-following capital and institutional attention.
For an options strategy, this does not mean “buy blindly.” That is a very important part of my process. An entry zone, a reclaim or even an all-time-high breakout is not automatically a buy signal. Every option idea still needs to pass the Option Feasibility + Risk Gate inside the CSE model.
That means I still need to check the premium size, bid/ask spread, liquidity, delta, expiry, time value, portfolio exposure and risk/reward before any position can become actionable. Especially with US megacap options, the chart can look strong while the option contract itself may still be too expensive or inefficient.
The current Apple case is therefore not about hype. It is about process. First the model identified Apple as a stock to watch. Then it waited for the right technical area. Now 291 has been reclaimed and the stock is breaking into all-time-high territory. That is the moment where Apple becomes a serious continuation candidate inside the CSE Capital Option Decision OS.
My view: Apple is now upgraded from a passive watchlist name to an active focus case. The bullish structure improves as long as 291 remains reclaimed and the breakout does not fail. If the stock holds above this zone and momentum continues to build, Apple can become one of the cleaner large-cap continuation setups in my option universe.
Structure first.
Confirmation second.
Option feasibility third.
No chase, no emotion, only process. Long 
